Myelodysplastic syndromes (MDSs) and acute myelogenous leukemia (AML) comprise a closely linked continuum of malignant hematologic diseases. Introduction.
Baylin
Stephen B
SB
Cancer Biology Division at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Mufti
Ghulam J
GJ
D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D015254:DNA Modification Methylases / Q000037:antagonists & inhibitors*; D044127:Epigenesis, Genetic; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000235:genetics; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000188:drug therapy* / Q000235:genetics
D000964:Antimetabolites, Antineoplastic; D015254:DNA Modification Methylases